Man‐Fung Yuen

43.8k total citations · 6 hit papers
528 papers, 23.1k citations indexed

About

Man‐Fung Yuen is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Man‐Fung Yuen has authored 528 papers receiving a total of 23.1k indexed citations (citations by other indexed papers that have themselves been cited), including 412 papers in Epidemiology, 369 papers in Hepatology and 67 papers in Surgery. Recurrent topics in Man‐Fung Yuen's work include Hepatitis B Virus Studies (364 papers), Hepatitis C virus research (326 papers) and Liver Disease Diagnosis and Treatment (274 papers). Man‐Fung Yuen is often cited by papers focused on Hepatitis B Virus Studies (364 papers), Hepatitis C virus research (326 papers) and Liver Disease Diagnosis and Treatment (274 papers). Man‐Fung Yuen collaborates with scholars based in Hong Kong, China and United States. Man‐Fung Yuen's co-authors include Ching‐Lung Lai, Wai‐Kay Seto, James Fung, Danny Ka‐Ho Wong, Thierry Poynard, Vlad Ratziu, Lung‐Yi Mak, John Chi–Hang Yuen, Ka Shing Cheung and Ivan Fan‐Ngai Hung and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Man‐Fung Yuen

515 papers receiving 22.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Viral hepatitis B

2003 1.4k citations Ching‐Lung Lai, Man‐Fung Yuen et al. profile →
Viral hepatitis C

2003 664 citations Man‐Fung Yuen, Ching‐Lung Lai et al. profile →
Hepatitis B virus infection

2018 572 citations Man‐Fung Yuen, Marion G. Peters et al. profile →
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score

2011 457 citations Man‐Fung Yuen, Vincent Wai‐Sun Wong et al. profile →
Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region

2016 391 citations Wai‐Kay Seto, Ching‐Lung Lai et al. profile →
Chronic hepatitis B virus infection

2018 364 citations Wai‐Kay Seto, Man‐Fung Yuen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Man‐Fung Yuen Hong Kong	77	16.7k	15.4k	3.0k	2.2k	1.8k	528	23.1k
Henry Lik‐Yuen Chan Hong Kong	90	20.9k 1.2×	16.2k 1.1×	3.4k 1.1×	2.9k 1.3×	2.0k 1.1×	440	28.2k
Raymond T. Chung United States	79	12.9k 0.8×	13.5k 0.9×	3.7k 1.2×	1.9k 0.8×	2.6k 1.4×	431	23.1k
Masashi Mizokami Japan	73	16.1k 1.0×	16.3k 1.1×	2.6k 0.9×	1.5k 0.6×	2.2k 1.2×	489	21.8k
Antonio Craxı̀ Italy	73	20.5k 1.2×	20.4k 1.3×	1.4k 0.5×	2.5k 1.1×	1.9k 1.0×	519	27.1k
Nezam H. Afdhal United States	76	13.2k 0.8×	13.2k 0.9×	2.2k 0.7×	2.0k 0.9×	1.4k 0.8×	343	19.6k
Osamu Yokosuka Japan	63	10.5k 0.6×	11.6k 0.8×	3.3k 1.1×	2.9k 1.3×	1.3k 0.7×	668	19.0k
Ansgar W. Lohse Germany	74	10.8k 0.6×	12.4k 0.8×	1.9k 0.6×	4.3k 1.9×	1.8k 1.0×	485	19.5k
Guido Gerken Germany	77	11.6k 0.7×	11.6k 0.8×	3.3k 1.1×	4.9k 2.2×	1.2k 0.7×	588	23.1k
Ching‐Lung Lai Hong Kong	95	28.0k 1.7×	27.6k 1.8×	2.5k 0.8×	3.8k 1.7×	4.3k 2.4×	598	36.2k
K. Rajender Reddy United States	88	24.9k 1.5×	28.3k 1.8×	2.4k 0.8×	5.3k 2.4×	3.9k 2.2×	586	37.2k

Countries citing papers authored by Man‐Fung Yuen

Since Specialization

Citations

This map shows the geographic impact of Man‐Fung Yuen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man‐Fung Yuen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man‐Fung Yuen more than expected).

Fields of papers citing papers by Man‐Fung Yuen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Man‐Fung Yuen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man‐Fung Yuen. The network helps show where Man‐Fung Yuen may publish in the future.

Co-authorship network of co-authors of Man‐Fung Yuen

This figure shows the co-authorship network connecting the top 25 collaborators of Man‐Fung Yuen. A scholar is included among the top collaborators of Man‐Fung Yuen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Man‐Fung Yuen. Man‐Fung Yuen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hui, Rex Wan‐Hin, et al.. (2025). Development and Validation of a High‐Sensitivity Droplet Digital PCR Assay for Serum Hepatitis B Virus DNA Detection. Journal of Viral Hepatitis. 32(4). e70023–e70023. 3 indexed citations

Hui, Rex Wan‐Hin, K.W. Chiu, Ho Ming Cheng, et al.. (2024). Multimodal multiphasic preoperative image-based deep-learning predicts HCC outcomes after curative surgery. Hepatology. 82(2). 344–356. 1 indexed citations

Zhang, Saisai, Lung‐Yi Mak, Man‐Fung Yuen, & Wai‐Kay Seto. (2024). Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B. Clinical and Molecular Hepatology. 31(Suppl). S182–S195. 7 indexed citations

Peters, Marion G., Man‐Fung Yuen, Norah A. Terrault, et al.. (2023). Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug Classes. Clinical Infectious Diseases. 78(4). 983–990. 5 indexed citations

Wong, Danny Ka‐Ho, et al.. (2023). Anti-HBc: a significant host predictor of spontaneous HBsAg seroclearance in chronic hepatitis B patients - a retrospective longitudinal study. BMC Gastroenterology. 23(1). 348–348. 6 indexed citations

Wei, E. P., Iris Y. Zhou, Man‐Fung Yuen, et al.. (2023). Portable electrical impedance tomography (EIT) system stages non-alcoholic fatty liver disease for potential screening and monitoring at home. PubMed. 2023. 1–4. 2 indexed citations

Wong, Samuel W. K., Sze Keong Tey, Xiaowen Mao, et al.. (2023). Small Extracellular Vesicle‐Derived vWF Induces a Positive Feedback Loop between Tumor and Endothelial Cells to Promote Angiogenesis and Metastasis in Hepatocellular Carcinoma. Advanced Science. 10(26). e2302677–e2302677. 19 indexed citations

Zhang, Saisai, Lung‐Yi Mak, Man‐Fung Yuen, & Wai‐Kay Seto. (2022). Screening strategy for non-alcoholic fatty liver disease. Clinical and Molecular Hepatology. 29(Suppl). S103–S122. 20 indexed citations

Mak, Lung‐Yi, Danny Wong, Alison Kuchta, et al.. (2022). Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B. Clinical and Molecular Hepatology. 29(1). 146–162. 15 indexed citations

10.

Zhang, Saisai, Hein M. Tun, Dengwei Zhang, et al.. (2022). Alleviation of Hepatic Steatosis: Dithizone-Related Gut Microbiome Restoration During Paneth Cell Dysfunction. Frontiers in Microbiology. 13. 813783–813783. 6 indexed citations

11.

Lee, Chi‐Ho, Wai‐Kay Seto, David Tak Wai Lui, et al.. (2021). Development of a Non-Invasive Liver Fibrosis Score Based on Transient Elastography for Risk Stratification in Patients with Type 2 Diabetes. Endocrinology and Metabolism. 36(1). 134–145. 8 indexed citations

12.

Mak, Lung‐Yi, Rex Wan‐Hin Hui, James Fung, et al.. (2020). Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B. Journal of Hepatology. 73(4). 800–806. 92 indexed citations

13.

Kao, Jia‐Horng, Tsung‐Hui Hu, Jidong Jia, et al.. (2020). East Asia expert opinion on treatment initiation for chronic hepatitis B. Alimentary Pharmacology & Therapeutics. 52(10). 1540–1550. 40 indexed citations

14.

Mak, Lung‐Yi, Michael Ko, Wai‐Pan To, et al.. (2019). Serum Mac‐2‐binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir‐treated chronic hepatitis B patients. Journal of Gastroenterology and Hepatology. 34(10). 1817–1823. 14 indexed citations

15.

Mak, Lung‐Yi, Wai‐Kay Seto, & Man‐Fung Yuen. (2019). Future Therapies for Functional Cure of Chronic HBV: Review of Investigational Drugs in Phase 1 and 2 Development. Current Hepatology Reports. 18(4). 503–511. 5 indexed citations

16.

Mak, Lung‐Yi, Chi‐Ho Lee, Ka Shing Cheung, et al.. (2019). Association of adipokines with hepatic steatosis and fibrosis in chronic hepatitis B patients on long‐term nucleoside analogue. Liver International. 39(7). 1217–1225. 15 indexed citations

17.

Fung, James, Tiffany Wong, Ksh Chok, et al.. (2017). Long‐term outcomes of entecavir monotherapy for chronic hepatitis B after liver transplantation: Results up to 8 years. Hepatology. 66(4). 1036–1044. 71 indexed citations

18.

Tan, Victoria P., et al.. (2017). Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia. Alimentary Pharmacology & Therapeutics. 45(6). 767–776. 103 indexed citations

19.

Seto, Wai‐Kay, James Fung, Ka Shing Cheung, et al.. (2016). Body‐mass index is associated with fibrosis regression during long‐term nucleoside analogue therapy in chronic hepatitis B. Alimentary Pharmacology & Therapeutics. 44(10). 1071–1079. 29 indexed citations

20.

Lo, C. M., Song Fan, Ching‐Lung Lai, et al.. (1999). Lamivudine prophylaxis in liver transplantation for hepatitis B in Asians. Transplantation Proceedings. 31(1-2). 535–536. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact